Robbin M Brodbeck

Title: Robbin M Brodbeck: Innovator in Melanin Concentrating Hormone Research

Introduction

Robbin M Brodbeck is a distinguished inventor based in Madison, Connecticut. She has made significant contributions to the field of melanin concentrating hormone research, holding a total of five patents. Her work focuses on the development of isolated polynucleotides and polypeptides that have potential therapeutic applications for both humans and animals.

Latest Patents

Brodbeck's latest patents include innovative findings related to monkey and canine melanin concentrating hormone receptors. These patents provide isolated polynucleotides encoding monkey and canine Melanin Concentrating Hormone (MCH) Type 2 receptors, along with chimeric polypeptides. The patents also detail vectors and cells for recombinant expression of such MCH receptor polypeptides. Additionally, her work on MCH receptor polynucleotides and polypeptides aims to identify agents that specifically interact with MCH receptors, which could be beneficial in therapies for conditions associated with MCH receptor activation. Another significant patent involves isolated polynucleotides encoding monkey Melanin Concentrating Hormone (MCH) Type 1 receptors, which also includes vectors and cells for recombinant expression.

Career Highlights

Robbin M Brodbeck is currently associated with Neurogen Corporation, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the field of hormone receptor research.

Collaborations

Brodbeck has collaborated with notable colleagues, including James E Krause and Andrew Y Thurkauf, contributing to the advancement of research in her area of expertise.

Conclusion

Robbin M Brodbeck's contributions to the field of melanin concentrating hormone research are noteworthy, and her patents reflect her commitment to advancing therapeutic options for various conditions. Her work continues to impact both human and animal health positively.